Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93


A high MELD score, combined with the presence of hepatitis C, is associated with a poor prognosis in living donor liver transplantation.

Ikegami T, Shirabe K, Yoshiya S, Yoshizumi T, Yamashita Y, Harimoto N, Toshima T, Uchiyama H, Soejima Y, Maehara Y.

Surg Today. 2014 Feb;44(2):233-40. doi: 10.1007/s00595-013-0523-7. Epub 2013 Feb 23.


Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.

Chok KS, Fung JY, Chan AC, Dai WC, Sharr WW, Cheung TT, Chan SC, Lo CM.

Ann Surg. 2017 Jan;265(1):173-177. doi: 10.1097/SLA.0000000000001671.


D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.

Ikegami T, Imai D, Wang H, Yoshizumi T, Yamashita Y, Ninomiya M, Iguchi T, Bekki Y, Shirabe K, Maehara Y.

Transplantation. 2014 Feb 27;97(4):457-62. doi: 10.1097/01.TP.0000435696.23525.d0.


Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.

Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS Jr, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE.

Hepatology. 2011 Oct;54(4):1313-21. doi: 10.1002/hep.24494.


Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.

Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.

Liver Transpl. 2003 Jul;9(7):737-40.


Diagnosing hepatitis C virus and improved outcomes in overall and kidney graft survival among simultaneous liver-kidney transplant recipients in the post-MELD era.

Latt NL, Alachkar N, Taydas E, Cameron A, Gurakar A.

Exp Clin Transplant. 2014 Mar;12 Suppl 1:45-9. Erratum in: Exp Clin Transplant. 2014 Apr;12(2):173. Alachka, Nada [corrected to Alachkar, Nada].


Adult-to-adult right-lobe living donor liver transplantation in recipients with hepatitis B virus-related benign liver disease and high model end-stage liver disease scores.

Jiang L, Yan L, Tan Y, Li B, Wen T, Yang J, Zhao J.

Surg Today. 2013 Sep;43(9):1039-48. doi: 10.1007/s00595-013-0539-z. Epub 2013 Mar 7.


D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.

Tanemura A, Mizuno S, Kato H, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S.

Transplant Proc. 2016 May;48(4):1025-31. doi: 10.1016/j.transproceed.2015.12.090.


Application of postoperative Model for End-Stage Liver Disease scoring system for evaluating liver graft function after living donor liver transplantation.

Toshima T, Ikegami T, Kimura K, Harimoto N, Yamashita Y, Yoshizumi T, Soejima Y, Ikeda T, Shirabe K, Maehara Y.

Transplant Proc. 2014 Jan-Feb;46(1):81-6. doi: 10.1016/j.transproceed.2013.09.034.


Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.

Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS.

Transplantation. 2011 Aug 27;92(4):453-60. doi: 10.1097/TP.0b013e3182259282.


Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.

Al Sebayel M, Abaalkhail F, Hashim A, Al Bahili H, Alabbad S, Shoukdy M, Elsiesy H.

Transplant Proc. 2015 May;47(4):1211-3. doi: 10.1016/j.transproceed.2015.01.024.


Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation.

Ma Y, Wang Q, Yang J, Yan L.

PLoS One. 2015 Sep 17;10(9):e0136604. doi: 10.1371/journal.pone.0136604. eCollection 2015.


Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.

Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS Jr, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB; A2ALL Study Group.

Liver Transpl. 2007 Jan;13(1):122-9.


Re-evaluation of the predictive score for 6-month graft survival in living donor liver transplantation in the modern era.

Yoshizumi T, Ikegami T, Bekki Y, Ninomiya M, Uchiyama H, Iguchi T, Yamashita Y, Kawanaka H, Shirabe K, Maehara Y.

Liver Transpl. 2014 Mar;20(3):323-32. doi: 10.1002/lt.23804.


Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.

Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.

Liver Transpl. 2009 May;15(5):496-503. doi: 10.1002/lt.21606.


Variant outcomes of liver transplantation for hepatitis C virus patients in different age categories: impact of the model for end-stage liver disease score.

Hu Z, Zhou J, Li Z, Xiang J, Zhang Q, Yan S, Wu J, Zhang M, Wang W, Zheng S.

J Hepatobiliary Pancreat Sci. 2017 Apr;24(4):206-216. doi: 10.1002/jhbp.435. Epub 2017 Mar 19.


The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.

Agopian VG, Petrowsky H, Kaldas FM, Zarrinpar A, Farmer DG, Yersiz H, Holt C, Harlander-Locke M, Hong JC, Rana AR, Venick R, McDiarmid SV, Goldstein LI, Durazo F, Saab S, Han S, Xia V, Hiatt JR, Busuttil RW.

Ann Surg. 2013 Sep;258(3):409-21. doi: 10.1097/SLA.0b013e3182a15db4.


Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation.

Ishigami M, Honda T, Okumura A, Ishikawa T, Kobayashi M, Katano Y, Fujimoto Y, Kiuchi T, Goto H.

J Gastroenterol. 2008;43(5):363-8. doi: 10.1007/s00535-008-2168-7. Epub 2008 Jul 1.


Supplemental Content

Support Center